VE-BASKET, a first-in-kind, phase II, histology-independent "basket" study of vemurafenib (VEM) in nonmelanoma solid tumors harboring BRAF V600 mutations (V600m) Meeting Abstract


Authors: Hyman, D. M.; Blay, J. Y.; Chau, I.; Raje, N. S.; Fernandez, M. E. E.; Wolf, J.; Sirzén, F.; Veronese, M. L.; Mitchell, L.; Puzanov, I.; Baselga, J.
Abstract Title: VE-BASKET, a first-in-kind, phase II, histology-independent "basket" study of vemurafenib (VEM) in nonmelanoma solid tumors harboring BRAF V600 mutations (V600m)
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613202798
PROVIDER: wos
DOI: 10.1200/jco.2014.32.15_suppl.2533
Notes: Meeting Abstract: 2533^ -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. David Hyman
    352 Hyman
  2. Jose T Baselga
    483 Baselga